Molecular changes induced by repeated restraint stress in the heart: the effect of oxytocin receptor antagonist atosiban

Canadian Journal of Physiology and Pharmacology
Monika BartekováDaniela Jezova

Abstract

Even though stress belongs to the most common lifestyle risk factors of cardiovascular diseases, there are only limited data on direct influence of stressors on the heart. The aim of the present study was to explore selected protein signaling pathways in response to repeated immobilization stress in the heart tissue. Effects of simultaneous treatment with atosiban, an oxytocin receptor antagonist, on stress-induced changes in the heart were also investigated. Male Wistar rats were exposed to repeated immobilization (2 h daily, lasting 2 weeks). The results showed increased phosphorylation of Akt kinase, enhanced levels of Bcl-2, and decreased levels of cleaved caspase-3 in the left ventricle in response to chronic stress independently of the treatment. Exposure to restraint led to the rise of HSP-90 and p53 in vehicle-treated rats only. Stress failed to modify MMP-2 activity and ultrastructure of the heart tissue. Treatment with the oxytocin/vasopressin receptor antagonist atosiban reversed stress-induced rise in HSP-90 and p53 proteins. In conclusion, our data demonstrate that repeated restraint stress induces Akt kinase activation and this is associated with elevation of anti-apoptotic proteins (Bcl-2) and down-regulation of ...Continue Reading

References

Jul 9, 1992·Nature·H WiechU Jakob
Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M J BlakeN J Holbrook
Mar 1, 1989·Journal of Molecular and Cellular Cardiology·F Z Meerson, Malyshev IYu
Dec 29, 1995·Annals of the New York Academy of Sciences·D JezovaM Vigas
Oct 23, 1997·Proceedings of the National Academy of Sciences of the United States of America·J GutkowskaS M McCann
Sep 29, 1998·Biochemical Pharmacology·T Scheibel, J Buchner
May 17, 2000·Proceedings of the National Academy of Sciences of the United States of America·M JankowskiJ Gutkowska
Sep 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·S SatoT Tsuruo
Jun 29, 2001·Experimental Physiology·S ThorntonD Slater
Dec 12, 2002·Cellular and Molecular Life Sciences : CMLS·D Picard
Sep 11, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Derek J HausenloyDerek M Yellon
Sep 20, 2005·British Journal of Pharmacology·Csaba SõtiPéter Ferdinandy
Oct 4, 2006·Molecular and Cellular Biochemistry·Tána RavingerováFrantisek Kolár
Feb 24, 2009·Canadian Journal of Physiology and Pharmacology·Maria OndrejcakovaDaniela Jezova
Apr 4, 2009·Physiological Reviews·Richard KvetnanskyMiklos Palkovits
Apr 8, 2010·General Physiology and Biophysics·Anna SpánikováMiroslav Barancík
Jun 12, 2010·Stress : the International Journal on the Biology of Stress·M OndrejcakovaD Jezova
Sep 28, 2012·Molecular and Cellular Biochemistry·Mária KovácsAgnes Végh
Oct 11, 2012·General Physiology and Biophysics·Maria OndrejcakovaDaniela Jezova
Nov 20, 2012·Journal of cardiology·Maryam MoghimianYaser Azizi
Jul 28, 2013·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·V DanevovaD Jezova
May 24, 2014·International Journal of Cardiology·Ahmed MenaouarJolanta Gutkowska
Jan 23, 2015·The Journal of Endocrinology·S BabicD Jezova

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.